Showing results (1491-1500 of 3,791) with videos related to

Sort By:
Pageof 380
Oncoimmunology|September 16, 2020
Endoscopical and pathological dissociation in severe colitis induced by immune-checkpoint inhibitorsCarlos Eduardo de Andrea, Jose Luis Perez-Gracia, Eduardo Castanon, et al.
Oncoimmunology|September 16, 2020
Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapyRomain Daillère, Lisa Derosa, Mélodie Bonvalet, et al.
Oncoimmunology|September 16, 2020
Trial watch: IDO inhibitors in cancer therapyJulie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, et al.
Oncoimmunology|September 17, 2020
Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patientsLawrence G Lum, Archana Thakur, Minsig Choi, et al.
Oncoimmunology|September 17, 2020
Immune responses during COVID-19 infectionCléa Melenotte, Aymeric Silvin, Anne-Gaëlle Goubet, et al.
Oncoimmunology|September 17, 2020
Firing up the cold tumors by targeting Vps34Bassam Janji, Meriem Hasmim, Santiago Parpal, et al.
Oncoimmunology|September 17, 2020
β-Catenin inhibition shapes tumor immunity and synergizes with immunotherapy in colorectal cancerCaihong Wang, Jingjing Yan, Pan Yin, et al.
Oncoimmunology|March 12, 2020
Prophylactic and therapeutic antileukemic effects induced by the AAC-11-derived Peptide RT53Justine Habault, Anna Kaci, Ewa Pasquereau-Kotula, et al.
Oncoimmunology|March 12, 2020
Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer modelShyambabu Chaurasiya, Annie Yang, Seonah Kang, et al.
Oncoimmunology|March 12, 2020
Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progressionZhiqi Xie, Tamami Ikegami, Yukio Ago, et al.
Pageof 380